Skip to main content
$17.99 $0.02 (0.1%)

04:00 PM EDT on 09/21/21

Bluebird Bio Inc. (NASDAQ:BLUE)

CAPS Rating: 4 out of 5

Current Price $17.99 Mkt Cap $1.2B
Open $17.97 P/E Ratio 0.00
Prev. Close $17.99 Div. (Yield) $0.00 (0.0%)
Daily Range $17.87 - $18.25 Volume 2,483
52-Wk Range $17.14 - $59.32 Avg. Daily Vol. 1,320,201

Caps

How do you think NASDAQ:BLUE will perform against the market?

Add Stock to CAPS Watchlist

All Players

242 Outperform
18 Underperform
 

All-Star Players

98 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BLUE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mdriver78 (74.69)
Submitted May 07, 2020

A company making big strides in gene therapies for genetic diseases and cancer. As a "clinical-stage company," Bluebird performs a lot of the early research to see what does and doesn’t work on certain diseases. Any treatments that Bluebird then… More

TMFacarchidi (< 20)
Submitted July 16, 2020

Extended delays with getting regulatory approval in the U.S., IP infringement lawsuits against them, and competing in several very crowded disease therapeutics markets where it has no clear product advantage over the competition.

NASDAQ:BLUE VS S&P 500 (SPY)

Fools bullish on NASDAQ:BLUE are also bullish on:

Fools bearish on NASDAQ:BLUE are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about BLUE.

Recs

0
Member Avatar mrjrdy (56.10) Submitted: 8/16/2021 11:16:06 PM : Outperform Start Price: $18.11 NASDAQ:BLUE Score: +1.73

The way the market moves

Recs

0
Member Avatar TMFjimhalley (39.35) Submitted: 6/10/2021 5:34:19 PM : Outperform Start Price: $34.25 NASDAQ:BLUE Score: -49.69

Biotech with a burgeoning portfolio of gene-editing therapies should shoot up once any of its therapies is approved and several are in Phase 3 trials.

Recs

0
Member Avatar Car12703 (61.43) Submitted: 4/25/2021 9:19:00 AM : Outperform Start Price: $28.50 NASDAQ:BLUE Score: -40.75

Positive conviction rating.

Leaderboard

Find the members with the highest scoring picks in BLUE.

Score Leader

DoubleBagel

DoubleBagel (35.95) Score: +669.10

The Score Leader is the player with the highest score across all their picks in BLUE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
secohen11 30.51 7/2/2013 Underperform 1Y $26.20 -31.34% +169.11% +200.45 0 Comment
MotleyFolJohn < 20 2/2/2015 Underperform 1Y $93.98 -80.86% +117.14% +198.00 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. CommodityBuyer < 20 7/10/2015 Underperform 5Y $160.69 -88.80% +109.06% +197.87 0 Comment
saab93boi < 20 6/19/2013 Underperform 5Y $25.68 -29.93% +163.72% +193.66 0 Comment
rwpaules 75.41 6/19/2013 Underperform 3Y $25.09 -28.30% +162.02% +190.32 0 Comment
pro64grammer 28.52 12/9/2014 Underperform 5Y $79.58 -77.39% +111.83% +189.23 0 Comment
GreenAB 27.77 3/5/2015 Underperform NS $106.20 -83.06% +105.74% +188.80 0 Comment
biotechf 85.66 1/22/2016 Underperform 3M $44.44 -59.52% +129.02% +188.54 0 Comment
coptermech66 < 20 10/29/2015 Underperform 3Y $79.54 -77.38% +107.65% +185.03 1 Comment
3rdChanceTom 87.03 3/11/2016 Underperform 5Y $45.77 -60.69% +115.44% +176.13 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BLUE.